Change provisions of the Nebraska Medical Cannabis Patient Protection Act and the Nebraska Medical Cannabis Regulation Act and provide for regulation of medical cannabis
LB651 would substantially revise Nebraska’s medical cannabis framework by amending the Nebraska Medical Cannabis Patient Protection Act and creating a detailed Nebraska Medical Cannabis Regulation Act. The bill defines key terms, establishes who may qualify as a patient or caregiver, sets possession limits, and creates protections for qualified patients and registered caregivers from arrest, prosecution, and certain civil or professional penalties when acting within the law. It also sets out rules for written recommendations from health care practitioners, patient and caregiver registration, confidentiality of registry information, and procedures for renewal, loss, theft, surrender, and disposal of cannabis.
The measure also creates a comprehensive licensing and regulatory structure for the cultivation, processing, manufacturing, testing, distribution, and dispensing of medical cannabis. It establishes a Nebraska Medical Cannabis Commission within the Nebraska Liquor Control Commission, authorizes licensing for cultivators, dispensaries, product manufacturers, testing facilities, and vertical licensees, and gives the commission broad rulemaking, inspection, enforcement, and disciplinary powers. The bill further addresses packaging, labeling, product potency limits, track-and-trace systems, security, advertising restrictions, local zoning and setback authority, and tax treatment for medical cannabis sales, while also revising related controlled substances, drug paraphernalia, liquor control, food, and tax statutes to conform to the new medical cannabis system.
LB651 would significantly alter Nebraska law by carving medical cannabis out of the state’s general controlled-substances framework and replacing it with a separate, regulated medical cannabis system. It would amend multiple statutes to exempt lawful medical cannabis activity from certain criminal penalties, create new licensing categories and regulatory authority, impose a special sales and use tax on medical cannabis, and direct tax revenue to the Medical Cannabis Control Fund and local governments. The bill would also affect employers, schools, health care settings, local governments, and law enforcement by setting boundaries on where cannabis may be used, how it may be transported or stored, and what local restrictions may be adopted.
The bill appears to have been introduced as a major policy overhaul intended to implement and regulate medical cannabis in Nebraska, suggesting a generally supportive or at least implementation-focused intent in the text itself. However, the available record shows no committee transcript or vote history, and the bill was ultimately indefinitely postponed, indicating that it did not advance and likely faced insufficient support or unresolved concerns. Because no recorded discussion is provided, the broader sentiment can only be inferred from the bill’s comprehensive, regulatory approach rather than from explicit legislative debate.
The bill’s most likely points of contention are the scope of legalization, the breadth of regulatory authority, and the balance between patient access and public safety. The measure gives the commission extensive control over licensing, inspections, enforcement, and product standards, while also allowing local governments to impose zoning and other restrictions; those provisions could draw concern from both advocates of broader access and local officials seeking control. Other likely flashpoints include the special cannabis tax, employer and school restrictions, limits on possession and product potency, residency and ownership requirements for licensees, and the bill’s detailed criminal and administrative penalties for violations. The lack of committee transcript prevents identification of specific speakers, but the structure of the bill suggests that patients, caregivers, and industry participants would favor access and clarity, while opponents or skeptics would focus on enforcement, youth access, and regulatory burden.